bioshares

On 26/8/11 Bioshares had this to say about TIS:-

"Wound healing company
Tissue Therapies may be a beneficiary of
the failure of Dermagraft in a pivotal venous
leg ulcer trial."

Unfortunately I am not a subscriber so was unable to read the commentary.

Looking good.

Let's hope that some announcement is forthcoming before the Wound Management Conference "WOUND CARE - NEW HORIZONS" being held at Jupiters Casino in Townsville from 8 - 10 September.

International Keynote Speakers are Professor Keith Harding who as we are all aware is doing the analysis of the EU trials PLUS Jacqui Fletcher, Senior Professional Tutor also from Cardiff University.

Professor Zee Upton and Professor Helen Edwards from QUT have a joint presentation for an hour on Saturday morning entitled "Wound Management Innovation Cooperative Research Centre - An Australian Collaborative Research Initiative to Transform Wound Outcomes".

Exciting times ahead methinks!

Regards.................